However, the disappointing results of TLR4 inhibitors as anti-sepsis drugs in clinical trials indicate that an LPS-induced injury mechanism that is not related to TLR4 may play a key role (Cheng et al., 2017; Rathinam, Zhao, and Shao 2019). Here, TLR4 is linked to Sepsis.